[{"indications": "Indications\u00a0annual immunisation against seasonal\r\ninfluenza", "name": "INFLUENZA VACCINES", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "14 Immunological products and vaccines", "14.4 Vaccines and antisera", "Influenza vaccines", "INFLUENZA VACCINES"], "cautions": "Cautions\u00a0see section 14.1; increased\r\nrisk of fever in child under 5 years with Viroflu\u00ae, and in child 5\u20139 years with Enzira\u00ae or preparations\r\nmarketed by Pfizer or CSL Biotherapies; interactions: Appendix 1 (vaccines)", "side-effects": "Side-effects\u00a0see section 14.1; also\r\nreported febrile convulsions and transient thrombocytopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202380.htm", "doses": ["By intramuscular injection, adult and child over\r\n13 years, 0.5\u00a0mL as a single dose; child 6 months\u20133 years, 0.25\u20130.5\u00a0mL; 3\u201313 years 0.5\u00a0mL; for children 6\r\nmonths to 13 years who have not received seasonal influenza vaccine\r\npreviously, repeat after 4\u20136 weeks", "By intradermal injection, see under Intanza\u00ae below"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0annual immunisation against seasonal\r\ninfluenza", "name": "INFLUENZA VACCINES Seasonal influenza vaccine for intradermal use", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "14 Immunological products and vaccines", "14.4 Vaccines and antisera", "Influenza vaccines", "INFLUENZA VACCINES", "Seasonal influenza vaccine for intradermal use"], "cautions": "Cautions\u00a0see section 14.1; increased\r\nrisk of fever in child under 5 years with Viroflu\u00ae, and in child 5\u20139 years with Enzira\u00ae or preparations\r\nmarketed by Pfizer or CSL Biotherapies; interactions: Appendix 1 (vaccines)", "side-effects": "Side-effects\u00a0see section 14.1; also\r\nreported febrile convulsions and transient thrombocytopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/202381.htm", "doses": ["By intramuscular injection, adult and child over\r\n13 years, 0.5\u00a0mL as a single dose; child 6 months\u20133 years, 0.25\u20130.5\u00a0mL; 3\u201313 years 0.5\u00a0mL; for children 6\r\nmonths to 13 years who have not received seasonal influenza vaccine\r\npreviously, repeat after 4\u20136 weeks", "By intradermal injection, see under Intanza\u00ae below", "Name[Intanza\u00ae (Sanofi Pasteur)  ] Injection, suspension of formaldehyde-inactivated\r\ninfluenza virus (split virion, grown in fertilised hens\u2019 eggs), net\r\nprice, prefilled syringe, 9\u00a0micrograms (0.1\u00a0mL) = \u00a39.05; prefilled\r\nsyringe, 15\u00a0micrograms (0.1\u00a0mL) = \u00a39.05Excipients  include neomycinDose\u00a0by intradermal injection into deltoid region, adult 18\u201360 years, 9\u00a0micrograms as a single dose; adult over 60 years, 15\u00a0micrograms as a single dose"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}, {"indications": "Indications\u00a0annual immunisation against seasonal\r\ninfluenza", "name": "INFLUENZA VACCINES Seasonal influenza vaccines for intramuscular use", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "14 Immunological products and vaccines", "14.4 Vaccines and antisera", "Influenza vaccines", "INFLUENZA VACCINES", "Seasonal influenza vaccines for intramuscular use"], "cautions": "Cautions\u00a0see section 14.1; increased\r\nrisk of fever in child under 5 years with Viroflu\u00ae, and in child 5\u20139 years with Enzira\u00ae or preparations\r\nmarketed by Pfizer or CSL Biotherapies; interactions: Appendix 1 (vaccines)", "side-effects": "Side-effects\u00a0see section 14.1; also\r\nreported febrile convulsions and transient thrombocytopenia", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/6493.htm", "doses": ["By intramuscular injection, adult and child over\r\n13 years, 0.5\u00a0mL as a single dose; child 6 months\u20133 years, 0.25\u20130.5\u00a0mL; 3\u201313 years 0.5\u00a0mL; for children 6\r\nmonths to 13 years who have not received seasonal influenza vaccine\r\npreviously, repeat after 4\u20136 weeks", "By intradermal injection, see under Intanza\u00ae below", "Name[Influvac Sub-unit\u00ae (Abbott Healthcare) ] Injection, suspension of formaldehyde-inactivated influenza virus (surface antigen,\r\ngrown in fertilised hens\u2019 eggs), net price 0.5-mL prefilled syringe\r\n= \u00a35.22Excipients  include gentamicin"], "pregnancy": "Pregnancy\u00a0not known to be harmful"}]